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SUMMARY
Cell-cycle phase is a critical determinant of the
choice between DNA damage repair by nonhomol-
ogous end-joining (NHEJ) or homologous recombi-
nation (HR). Here, we report that double-strand
breaks (DSBs) induce ATM-dependent MOF (a
histone H4 acetyl-transferase) phosphorylation
(p-T392-MOF) and that phosphorylated MOF coloc-
alizes with g-H2AX, ATM, and 53BP1 foci. Mutation
of the phosphorylation site (MOF-T392A) impedes
DNA repair in S and G2 phase but not G1 phase
cells. Expression of MOF-T392A also blocks the
reduction in DSB-associated 53BP1 seen in wild-
type S/G2 phase cells, resulting in enhanced
53BP1 and reduced BRCA1 association. Decreased
BRCA1 levels at DSB sites correlates with defective
repairosome formation, reduced HR repair, and
decreased cell survival following irradiation. These
data support a model whereby ATM-mediated
MOF-T392 phosphorylation modulates 53BP1 func-
tion to facilitate the subsequent recruitment of HR
repair proteins, uncovering a regulatory role for
MOF in DSB repair pathway choice during S/G2
phase.
INTRODUCTION
TheMOF (males absent on the first) MYST familymember affects
ataxia telangiectasia mutated (ATM) function in response to
DNA damage and is essential for cell viability, proliferation, auto-
phagy, and oncogenesis (Bhadra et al., 2012; Fu¨llgrabe et al.,
2013; Gupta et al., 2005; Li et al., 2010; Sharma et al., 2010;
Taipale et al., 2005). MOF acetylates the lysine 16 residue of his-
tone H4 (H4K16), and this modification is critical for the DNA
damage response (DDR), as depletion of MOF abrogates repair
of double-strand breaks (DSBs) by both the nonhomologous
end-joining (NHEJ) and homologous recombination (HR) path-
ways (Sharma et al., 2010). Highly upregulated in the S and G2
phase, DNA DSB repair begins with the nucleolytic resection of
the 50 strands of the DNA break ends to generate 30 single-
stranded DNA. Although NHEJ is also functional in cells at G2
phase (Kakarougkas et al., 2013), the proximity of the appro-
priate sister chromatid or homologous chromosomes is likely a
key regulatory step for preferential initiation of HR. The potential
role of chromatin modifying factors in facilitating the HR pathway
remains unknown. It is known, however, that the end resection of
DNA DSB to permit repair by HR is activated by cyclin-depen-
dent kinase (CDK) phosphorylation of CtIP (Sartori et al., 2007),
the 50 DNA resection nuclease in S/G2. In G1, this process is
blocked by 53BP1 (also called TP53BP1) (Bothmer et al.,
2010), a well-known DDR factor that is recruited to nuclear struc-
tures at DNA damage sites forming readily visualized ionizing
radiation (IR)-induced foci. Depletion of 53BP1 results in
genomic instability in human as well as mouse cells, and its
absence also results in cell-cycle arrest in G2/M phase. The
53BP1 protein is classified as an adaptor/mediator, because it
is required for processing of the DDR signal and as a platform
for recruiting additional repair factors involved in both DSB repair
and cell-cycle control. It has been proposed that the key deter-
minant in choosing the preferred DSB repair pathway lies in
the initial processing of the DSB ends, which is regulated during
the cell cycle (Symington and Gautier, 2011). For instance, in
cells at G1 phase, 53BP1 inhibits DNA end resection of DSBs,
thus favoring repair by the NHEJ pathway. However, in S/G2
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phase, end resection of DNA DSB is initiated at the 50 DSB to
produce a 30 single-stranded overhang that facilitates HR-
mediated repair (Bothmer et al., 2010, 2011; Symington and
Gautier, 2011; West, 2003). Thus, 53BP1 is a critical determinant
in choosing the appropriate DSB repair pathway in G1 and S/G2
phase cells (Chapman et al., 2012).
Inhibition of DNA end-resection by 53BP1 during theG1 phase
is required (Anbalagan et al., 2011; Bonetti et al., 2010) in order to
shift the repair pathway to the NHEJ pathway (Morales et al.,
2003; Nakamura et al., 2006; Oksenych et al., 2012; Ward
et al., 2003; Zimmermann et al., 2013), because a homologous
DNA template is not available to carry out HR-dependent repair.
Conversely, inhibition of 53BP1 activity by BRCA1 in S/G2 phase
cells appears to be critical because there is increased genomic
instability in BRCA1-deficient cells due to 53BP1-dependent
NHEJ repair during S/G2, as a result of resection suppression
(Bunting et al., 2010). Callen and colleagues have reported that
PTIP (also known as PAXIP) contributes to DNA DSB repair
pathway preference, because cells deficient for PTIP are tolerant
of DNA damaging agents that are toxic to cells deficient in DSB
repair via the HR pathway, arguing that PTIP-like 53BP1 plays a
critical role in NHEJ (Callen et al., 2013; Escribano-Diaz and
Durocher, 2013).
The cellular response to IR andDNADSB repair dependson the
protein kinase ATM (Matsuoka et al., 2007; Pandita et al., 2000;
Pandita, 2003; Shiloh and Ziv, 2013), which is influenced by
MOF. In addition to binding chromatin (Sharma et al., 2010),
MOF also associates with ATM (Gupta et al., 2005; Sharma
et al., 2010). In this study, we present evidence that MOF is phos-
phorylatedat the threonine392residue (pT392-MOF)byATMsub-
sequent to IR-induced DNA damage. Phosphorylation of MOF
by ATM is functionally significant because it was required to facil-
itate recruitment of HR-related repair proteins to DNA damage
sites during S/G2 phase. Our results provide mechanistic insights
into the potential role of pT392-MOF in regulating key proteins
involved in choosing the appropriate DNA DSB repair pathway.
RESULTS
ATM-Dependent Phosphorylation of MOF
Given the importance of MOF in DNA repair (Gupta et al., 2014;
Peterson and Almouzni, 2013; Sharma et al., 2010), we first
asked whether IR exposure induces phosphorylation of MOF.
Analysis of MOF immunoprecipitated from human cell extracts
with a pan-phospho-serine antibody detected basal-level MOF
serine phosphorylation that was unchanged after irradiation
and unaffected by cellular ATM status (Figure 1A). In contrast,
IR induced MOF threonine phosphorylation in an ATM-depen-
dent manner (Figure 1A). Antibody for ATM-specific SQ/TQ
phosphorylation sites also detected a postirradiation increase
in MOF phosphorylation in ATM expressing cells. KU55933
blocked the increase in MOF SQ/TQ phosphorylation, confirm-
ing the ATM dependence of MOF phosphorylation after IR expo-
sure (Figure 1B). The human andmouseMOF sequences contain
only one SQ and one TQ site (Figure S1A). Substitution of MOF
threonine 392 with alanine (T392A) resulted in loss of ATM-
dependent IR-induced phosphorylation. Western blot analysis
of immunoprecipitated MOF from control and irradiated cells
with a polyclonal rabbit phosphospecific T392-MOF antibody re-
vealed an increase in endogenous pT392-MOF postirradiation
(Figure 1C). Similarly, Flag-tagged MOF expressed in 293T cells
also displayed increased Flag-MOF-T392 phosphorylation post-
irradiation (Figure 1C), whereas phosphorylation of Flag-tagged
MOF-T392A was not detected (Figure 1C). This result confirms
that the single MOF TQ site at threonine 392 is the only IR- and
ATM-dependent MOF phosphorylation site (Figure 1A). In an
in vitro kinase assay (Gupta et al., 2005; Lee and Paull, 2004),
ATM directly phosphorylates MOF (Figure 1D) but not the
MOF-T392A mutant (Figure 1D). Postirradiation phosphorylation
of MOF-T392 is also independent of ATR (Figure 1E) further con-
firming ATM as the responsible kinase (Figure 1E). Cellular levels
of MOF protein in G1 and S/G2 phase cells were similar and un-
affected by irradiation but the IR-induced increase in pT392-
MOF levels was highest in S/G2 phase cells (Figure 1F). Mutation
of the ATM phosphorylation site in MOF-T392A had no effect on
MOF acetylation activity, whether measured by in vitro histone
H4K16 acetylation (Figures 1G and S1B) or MOF autoacetylation
in vivo (Figure 1H). This result is consistent with PONDER anal-
ysis of the wild-type MOF and MOF-T392A protein structures
(Obradovic et al., 2005), which indicated no major structural dif-
ferences were introduced by the threonine/alanine substitution,
whereas the phospho-mimic MOF-T392E mutation induced
localized structural changes (Figure S1C). Together, these re-
sults suggest that ATM-dependent phosphorylation may regu-
late MOF functions.
Role of MOF Phosphorylation during S and G2 Phases
Expression ofMOF-T392A in cells cotransfectedwith small inter-
fering RNA (siRNA) specific for the endogenous MOF 30 UTR did
not result in anymajor changes in cell viability 96 hr posttransfec-
tion (Figures S2A and S2B; data not shown). Despite a reduction
of endogenous MOF to nearly undetectable levels (Figure S2A),
H4K16ac levels were largely preserved over this time period (Fig-
ure S2C) when MOF-T392A was expressed, which is consistent
with the in vitro (Figures 1G and S1C) and in vivo (Figure 1H) acet-
ylation results. However, after exposure to IR, there was signifi-
cantly reduced survival of MOF-siRNA transfected exponentially
growing cells, an outcome partially rescued by MOF-T392A
expression (Figure 2A). The partial rescue suggested that
the role of MOF phosphorylation may be limited to a specific
phase(s) of the cell cycle. This possibility was examined further
by analysis of synchronized cell populations. Cellswith orwithout
expression of MOF-T392A, with and without depletion of endog-
enousMOF (Figures S2D and S2E) were enriched in G1 phase by
serum depletion, in S phase by thymidine block and in G2/M
phase (Table S1) by releasing from thymidine block for measure-
ment of survival postirradiation. Mutant MOF-T392A expression
did not alter the survival of irradiated G1 phase cells (Figure 2B).
In contrast, S as well as G2/M phase cells expressing mutant
MOF-T392A with depleted endogenous MOF (Figures S2D and
S2E) had reduced cell survival after IR exposure as compared
to cells expressing wild-type MOF (Figures 2C and 2D). The sur-
vival differences were not due to dominant-negative effects, as
the endogenous MOF was simultaneously depleted by specific
siRNA or cre-mediated gene deletion or a resistant MOF was
expressed (Figures S2C, S2D, and S3A–S3C; data not shown).
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Furthermore, phospho-mimic MOF-T392E expression in cells
depleted of endogenousMOF, did not show increased cell killing
postirradiation, neither in exponential phase cells or G1, S, or G2
phase-enriched cells (Figures 2A–2D), confirming the role of
phospho-MOF in S and G2 phase cell survival postirradiation.
We ascertained the effect of MOF-T392A expression on the
frequency of IR-induced chromosomal and chromatid-type ab-
errations observed at metaphase: (1) G1-specific aberrations
are mostly of the chromosomal type (dicentric with acentric frag-
ment), with a few involving chromatids in human (Figure S4A); (2)
S-type aberrations are both chromosome as well as chromatid
type in human (Figure S4B) and; (3) G2-type aberrations are
predominantly the chromatid type with the least number of
dicentrics in human cells (Figure S4C) (Gupta et al., 2005). Similar
aberrations were also examined in G1, S, and G2 phase mouse
cells (Figures S4D–S4H). No differences were found in residual
IR-induced G1-type chromosomal aberrations in cells with and
without expression of mutant MOF-T392A, whereas cells with
MOF depletion alone had an increased number of G1-type chro-
mosome aberrations (Figure 2E). Cells with MOF depletion alone
had much higher IR-induced S phase-specific residual chro-
matid/chromosome aberrations as observed at metaphase (Fig-
ure 2F) compared to control siRNA-treated cells. Expression of
the phosphorylation mutant MOF-T392A in these cells failed to
rescue this defect. As in S phase cells, a higher frequency of
chromosomal aberrations was observed in MOF-depleted G2
phase cells, which could not be complemented by MOF-T392A
mutant expression (Figure 2G). The increase in S- or G2-type
chromosome aberrations could possibly be due to cell-cycle
checkpoint defects that can affect chromosome repair, but anal-
ysis of irradiated G2 phase cells treated with caffeine indicated
the increased frequency of G2-type chromosomal aberrations
was independent of mutant MOF-T392A (Figure 2H). This sug-
gests that the higher frequency of G2-specific chromosome ab-
errations observed in cells with mutant MOF-T392A is not due to
a cell-cycle checkpoint defect. The ability of the T392A
Figure 1. ATM-DependentMOFPhosphory-
lation
(A) Cells with (AT221JE-TpEBS7-YZ5) (+ATM) and
without (AT221JE-TpEBS7) (ATM) ATM were
irradiated, the MOF protein immunoprecipitated
and blotted with phospho-serine (p-Ser), phos-
pho-threonine (p-Thr), and phospho-serine gluta-
mine/threonine glutamine (p-SQ/TQ) antibodies.
(B) HEK293 cells with and without KU 55933
treatment were irradiated, and MOF protein was
immunoprecipitated and blotted with pSQ/TQ
antibody.
(C) HEK293 cells were irradiated and collected at
different timepoints postirradiation: (i)MOFprotein
was immunoprecipitated with MOF antibody and
blotted with polyclonal pT392-MOF antibody
raised in rabbit; (ii) Flag-MOF protein was immu-
noprecipitated by Flag antibody and blotted with
pT392-MOF antibody; and (iii) HEK293 cells ex-
pressing Flag-MOF-T392A were irradiated,
immunoprecipitated by Flag antibody, and blotted
with pT392-MOF antibody.
(D) The ATM kinase assay was performed as
described (Gupta et al., 2005). The GST-MOF and
the recombinant MRN complex was expressed in
Sf21 insect cells with a baculovirus system and
purified by nickel affinity, ion exchange, and gel
filtration chromatography (Gupta et al., 2005): (i)
wild-type GST-MOF incubated with different
combinations and MOF phosphorylation requires
ATM; and (ii) kinase assay performed with wild-
type and mutant MOF-T392A.
(E) Effect of ATR depletion on IR-induced MOF
phosphorylation: (i) knockdown of ATR with spe-
cific siRNA; and (ii) western blot showing IR-
induced MOF phosphorylation in ATR-depleted
cells.
(F) Detection of phospho-MOF postirradiation in
different phases of cell cycle: (i) western blot
showing MOF and phospho-MOF in G1 and S/G2
phase-enriched cells; and (ii) quantitation of relative p-T392-MOF levels in G1 and S/G2 phase-enriched cells (**p < 0.01 as determined by the chi-square test).
(G) In vitro acetylation activity assay of mutant and wild-type MOF.
(H) Cells with and without ATM expressing wild-type or mutant MOF were irradiated, MOF immunoprecipitated and analyzed for acetylation status by using pan-
acetylation antibody.
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Figure 2. Mutant MOF Abrogates Survival and Chromosome Repair
Effect of MOF-T392A on survival, chromosome aberrations, and DSB repair, postirradiation.
(A–D) Clonogenic survival after IR dose of 6 Gy, exponential population (A), G1 phase population (B), S phase population (C), and G2 phase population (D).
(legend continued on next page)
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phosphorylation defective MOF mutant to complement wild-
typeMOF depletion in G1 phase but not in S/G2 phase cells sug-
gests an important role for MOF phosphorylation in the HR repair
pathway. Furthermore, we also validated the data in mouse cells
in which endogenous MOF was subjected to cre-mediated dele-
tion and mutant MOF-T329A or wild-type MOF was expressed
(Figures S3B and S3C). MOF deletion resulted in loss of cell pro-
liferation (Figure 2I). No defect in G1 chromosome repair postir-
radiation was observed in mouse cells expressing MOF-T392A
(Figure 2E), whereas a defect in repair of S- and G2-type chro-
mosomes was observed (Figures 2J–2L), results consistent
with those in human cells.
We directly tested whether mutant MOF-T392A impacts either
or both DNA DSB repair pathways by using engineered cell lines
that express a fluorescent protein only upon repair of I-SceI-
induced DSBs by the appropriate pathway (Sharma et al.,
2010). Accurate repair of the NHEJ-dependent fluorescent pro-
tein gene template was restored by mutant MOF-T392A expres-
sion in MOF-depleted cells (Figure 2M), further confirming that
MOF phosphorylation is not required for DSB repair by the
NHEJ pathway. This is also consistent with the normal chromo-
somal damage repair observed in G1 phase cells complemented
with mutant MOF-T392A after endogenous MOF depletion (Fig-
ures 2E and 2J).
The reconstitution frequency of a GFP HR reporter gene within
a chromosomally integrated plasmid substrate (Pandita et al.,
2006; Pierce et al., 1999) was used to measure the dependence
of HR onMOF-T392 phosphorylation. In cells depleted of endog-
enous MOF, expression of the MOF-T392A failed to rescue the
HR repair defect as the number of GFP-positive cells was not
significantly increased (Figure 2N), whereas MOF-T392E phos-
pho-mimic expression did rescue the defect. These data sug-
gest that MOF phosphorylation at T392 is required for DNA
DSB repair by the HR pathway but not by NHEJ. We also
observed that after I-SceI induction the total levels of MOF do
not change, but the level of phosphorylated MOF significantly
increased (Figure 2O).
MOF Phosphorylation at DNA DSBs
Endogenous MOF is phosphorylated at T392 postirradiation
(Figure 1C) and a pT392-MOF-specific antibody readily detects
IR-induced foci formation (Figure 3A). Human or mouse cells
with MOF depletion did not show any IR-induced pT392-
MOF-specific foci (Figures 3B and 3C). Furthermore, in cells
expressing either Flag-tagged wild-type or Flag-tagged mutant
MOF-T392A, the phospho-specific MOF antibody only detected
IR-induced pT392-MOF foci in cells expressing wild-type MOF,
not mutant MOF-T392A (Figure 3D). IR-induced pT392-MOF
foci were observed in cells with ATM (Figure S5A), and IR-
induced p-T392-MOF foci colocalized with p-S1981-ATM, g-
H2AX, 53BP1, BRCA1, and RAD51 foci (Figures 3E–3G, S5B,
and S5C). However, the appearance and disappearance kinetics
of pT392-MOF foci were slower than those of g-H2AX foci (Fig-
ure 4A) suggesting that phosphorylated MOF foci may have a
role in the processing of a specific type of DNA DSB repair.
Because MOF is phosphorylated by ATM, we examined whether
expression of MOF-T392A influences the appearance and
disappearance of p-S1981-ATM foci, and as expected mutant
MOF had no influence on ATM foci formation but did delay the
disappearance of p-S1918-ATM foci (Figure 4B). Next, we deter-
mined whether loss of T392-MOF phosphorylation influenced
g-H2AX foci kinetics (Figure 4C). Cells expressing mutant
MOF-T392A did not show any major difference in H4K16ac
levels compared to cells expressing wild-typeMOF (Figure S1B),
and the initial appearance of IR-induced g-H2AX foci was similar
at 2 hr postexposure (Figure 4C). However, by 4 or 6 hr postirra-
diation there was a higher frequency of residual g-H2AX foci in
cells expressing MOF-T392A as compared to cells expressing
wild-type MOF (Figure 4C).
53BP1 Interaction with Phosphorylated MOF
It is known that 53BP1 enhances DSB repair by NHEJ and blocks
the recruitment of resection proteins associated with DSB repair
by HR (Bouwman et al., 2010; Bunting et al., 2010; Tang et al.,
2013). Cells expressing mutant MOF-T392A had higher levels
of residual 53BP1 foci (Figure 4D) as well as RIF1 foci (Figure 4E)
postirradiation. Because MDC1 depletion results in loss of
53BP1 foci formation postirradiation (Minter-Dykhouse et al.,
2008), we examined whether MOF-T392A expression affects
MDC1 accumulation, which may impair recruitment of HR-
related proteins like CtIP and Rad51. Expression of MOF-
T392A resulted in a higher frequency of cells with MDC1 foci
formation postirradiation (Figure 4F). We also found that the cells
expressing MOF-T392A show delayed kinetics of yellow fluores-
cent protein (YFP)-53BP1 disappearance at laser-track-induced
DNA damage (Figures 4G and 4H).
MOF Phosphorylation Affects ATM Dynamics and DNA
Retention
Expression of mutant MOF-T392A delayed the disappearance of
pS1981-ATM foci postirradiation (Figure 4B) while not affecting
H4K16 acetylation (Figures 1H and S1B). Live cell imaging of
microirradiated cells expressing ATM tagged with YFP (Figures
5A and 5B) did not detect any major effect of mutant MOF-
T392A expression on ATM accumulation, but the kinetics of
YFP-tagged ATM accumulation at the damage sites was
(E–G) Metaphase chromosome aberration of G1 type (E), S type (F), and G2 type (G).
(H) Cells treated with caffeine prior to exposure to IR. About 50 metaphases were scored for each experiment, and the data presented are the mean of three
experiments.
(I) Proliferation of floxedMOFMEF cells with or without tamoxifen treatment and expression of Mof-T392A. Cell numbers were determined at 96 hr after tamoxifen
treatment in cells with and without mMof.
(J–L) Metaphase chromosome aberration of G1 type (J), S type (K), and G2 type (L).
(M) I-SceI-induced DSBs by NHEJ.
(N) Impairment of I-SceI-induced HR in cells expressing MOF-T392A or cells with MOF depletion by specific siRNA.
(O) ChIP analysis in I-SceI-induced cells with and without knockdown of MOF examined for bound MOF and pT392-MOF. (*p < 0.05, **p < 0.01, ***p < 0.001, as
determined by the chi-square test).
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Figure 3. IR-Induced pT392-MOF Foci Colocalize
with DNA Repair Protein Foci
(A) 293 cells with and without Flag-MOF-T392A were
irradiated with 2 Gy, fixed postirradiation, and immuno-
stained for p-T392 MOF.
(B) MOF-depleted human cells do not show IR-induced
p-T329-MOF foci.
(C) MEF with cre-mediated MOF deletion do not show
IR-induced p-T392-MOF foci.
(D) Cells expressing MOF-T392A did not show pT392-
MOF foci. MOF-T392A was detected with Flag antibody.
(E–G) Colocalization of IR-induced p-T392-MOF foci
with p-S1981-ATM foci (E); with g-H2AX foci (F); and
with 53BP1 foci (G): (i) low magnification and (ii) high
magnification.
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modestly reduced. To determine whether the altered ATM
kinetics was due to altered retention of mutant MOF postirradia-
tion, we expressed Flag-tagged wild-type and mutant MOF-
T392A in HEK293 cells (Figure S2D), exposed the cells to 5 Gy,
and after increasing intervals isolated and crosslinked the DNA
for Flag antibody immunoprecipitation. The association of wild-
type MOF with DNA increased postirradiation, whereas
MOF-T392A association with DNA did not significantly increase
(Figure 5C), suggesting that phosphorylation enhances MOF
chromatin binding. We examined MOF retention in G1 and
Figure 4. Effect of MOF-T392A on Repair Protein Kinetics Postirradiation
(A) Human cells were irradiated with 2 Gy and immunostained with anti-pT392-MOF and g-H2AX.
(B) Kinetics of appearance and disappearance of p-S1981-ATM in cells with and without expression of MOF-T392A.
(C) Frequency of cells with g-H2AX foci in cells with and without mutant MOF-T392A expression.
(D and E) IR-induced 53BP1 (D), RIF1 (E) in cells with and without expression of MOF-T392A.
(F) IR-induced MDC1 foci in MEFs: (i) comparison of IR-induced MDC1 foci in cells with and without expression of mutant MOF; (ii) quantification of cells with
MDC1 foci.
(G) Cells with and without expression MOF-T329A, and MOF depletion by siRNA with expression of YFP 53BP1 were microirradiated.
(H) Initial accumulation and relative fluorescence for a 30 min time course of treatment with YFP-53BP1 at laser-generated DSBs. Error bars represent deviation
from three different experiments (*p < 0.05, **p < 0.01, as determined by the chi-square test).
Cell Reports 8, 177–189, July 10, 2014 ª2014 The Authors 183
S/G2 phase-enriched cells (Figures 5D and 5E) and found a sig-
nificant increase in the retention of wild-type MOF in S/G2 phase
cells, whereas no significant increase in mutant MOF retention
was observed. To avoid any competitive interference with
MOF-T392A binding to chromatin, endogenous MOF was
depleted using UTR-specific siRNA. Conversely, we determined
whether expression of mutant MOF-T329A affects the associa-
tion of wild-type MOF with chromatin by quantitating chro-
matin-bound MOF and MOF-T392A in cells expressing
Flag-tagged MOF-T392A and HA-tagged wild-type MOF after
endogenous MOF depletion cells by UTR-specific siRNA (Fig-
ure S2D) and quantitated MOF and MOF-T392A bound to chro-
matin (Figure S5B). Prior to irradiation, MOF-T392A expression
does decrease wild-type MOF association with chromatin, but
upon irradiation wild-type MOF and not mutant MOF-T392A
showed enhanced association with chromatin (Figure S6). We
further examined the effect of the MOF-T392A mutation on
ATM chromatin association in irradiated cells by isolating soluble
and chromatin-bound fractions (Figures 5F and 5G). In Flag-
tagged MOF-T392A expressing cells, as compared to wild-
type-transfected cells, western blot analysis of the chromatin-
bound proteins indicated there was a significant decrease in
chromatin-associated ATM. In addition, we found that MRE11
binding to chromatin is also reduced postirradiation in cells ex-
pressing MOF-T392A cells (Figures 5H and 5I). Phosphorylation
of MOF-T392 postirradiation, therefore, enhances chromatin
retention of MOF and a subset of other critical proteins required
for DNA damage repair.
ExpressionofmutantMOF-T392A affectedDNADSB repair in S
and G2 phase cells, where homologous recombination is upregu-
lated. Because 53BP1 is known to suppressDSB repair byHR,we
examined thecellular interactionofwild-typeandmutantMOFwith
53BP1 before and after irradiation. Immunoprecipitation studies
indicated a fraction of both wild-type (Figures 6A–6C) as well as
mutantMOF-T392A (Figures 6D–6F) associatedwith 53BP1under
nonstress conditions, and the interaction was not disrupted by
ethidium bromide (Figure S7A). The interaction of wild-type MOF
with 53BP1 increases immediately postirradiation and then de-
creases until, by 3 hr postirradiation, the complex largely disap-
peared. Only later, at 12 hr postirradiation, did the MOF/53BP1
complex reform to control levels (Figures 6B and 6C). In contrast,
the association of mutant MOF-T392A with 53BP1, while also
increasing following irradiation does not decline, being stable
over the next 6 hr period (Figures 6E and 6F). To further confirm
the in-cell association of wild-type MOF and mutant MOF-
T329A, we have used an in situ proximity ligation assay (PLA), in
which the close physical association of two proteins is visualized
by a fluorescent signal (Fredriksson et al., 2002; So¨derberg and
Lang, 2006). Both wild-type and mutant MOF-T392A associated
with 53BP1, but, whereas the 53BP1/MOF interaction declined
by 2 hr postirradiation, the mutant MOF-T392A did not dissociate
from 53BP1 over the course of 6 hr postirradiation recovery, a
Figure 5. Effect of MOF-T392A on ATM
Dynamics and Association with Chromatin
Postirradiation
(A) U2OS cells expressing YFP-ATM were trans-
fected with MOF-T392A, microirradiated, and
accumulation of YFP-ATM was monitored.
(B) Accumulation kinetics and relative fluores-
cence for a 60 min course of treatment with
YFP-ATM at laser-generated DSBs. Error bars
represent the SD from three independent experi-
ments.
(C–E) Comparison of MOF and MOF-T392A as-
sociation with chromatin after cells were exposed
to 5 Gy. ChIP was performed with an MOF or Flag-
MOF-T392A or Rb antibody, and DNA was quan-
tified by absorbance at 260 nm by NanoDrop 2000
in: (C) cells in exponential phase; (D) G1 phase;
and (E) S/G2 phase.
(F and G) Cells with and without expression of
MOF-T392 were analyzed for chromatin fraction
versus soluble fraction of ATMbywestern blotting:
(F) ATM was detected with a specific ATM anti-
body and (G) relative levels of ATM.
(H and I) Cells with and without expression
of MOF-T392A were analyzed for the retention
of MRE11 by western blotting postirradiation
(H) and histogram showing relative accumula-
tion MRE11 (I). The mean are from three
different experiments (*p < 0.05, **p < 0.01,
***p < 0.001, as determined by the chi-square
test).
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result similar to the immunoprecipitation studies (Figures 6G–
6I). Together, these results suggest a mechanism whereby phos-
phorylation of MOF at T392 may be required for 53BP1 release
from DSB sites, a step required prior to recruitment of proteins
involved in DSB repair by HR.
The protein domains involved in the MOF and 53BP1 interac-
tion were mapped by deletion analysis. Binding of purified
53BP1 to GST-tagged MOF deletion mutants identified the
MOF N-terminal region between amino acids 65–165 as medi-
ating 53BP1 binding (Figure 6J). Similar analysis using whole-
cell extracts expressing mutants of 53BP1 identified the 53BP1
N-terminal domain as required for interaction with added, puri-
fied GST-MOF (Figure 6K).
Figure 6. MOF Phosphorylation Decreases
Interaction with 53BP1 Postirradiation
(A–F) The interactions between 53BP1 with wild-
type MOF (A) and MOF-T392A (D). (B) Cells irradi-
ated with 10 Gy and fixed at different times for
immunoprecipitation. (C) Relative association of
53BP1 with MOF. (E) Interaction between 53BP1
and MOF-T392A as determined by immunoprecip-
itation and western blot. Cells irradiated with 10 Gy
and fixedat different times for immunoprecipitation.
(F) Relative association of 53BP1 with MOF-T392A.
(G) Control (unirradiated) cells showing PLA foci of
FLAG (for MOF) versus 53BP1 detected by the
described procedure (Fredriksson et al., 2002;
Hegde et al., 2012). The nuclei were counter-
stained with DAPI, and the PLA signals were
visualized in a fluorescence microscope.
(H) Cells irradiated with 3 Gy and examined for PLA
foci at different times postirradiation.
(I) Histogram showing number of PLA-FLAG (MOF)
versus 53BP1 foci per cell in cells expressing wild-
type and mutant MOF that were determined by
coimmunoprecipitation as well as by proximity
ligation assay (PLA).
(J) Mapping of 53BP1 binding site in hMOF. The
domains of hMOF and interaction with 53BP1 were
conducted as described previously (Gupta et al.,
2005).
(K)Mappingof hMOFbinding site in 53BP1: (a) 293T
cells were transfected with either 53BP1WT-FLAG
or truncated 53BP1-FLAG. (b) hMOF-GST fusion
proteinwas expressed in bacteria, and immobilized
hMOF was incubated with the whole-cell lysates
prepared from 53BP1 WT-FLAG (1–1,973 aa),
53BP1 DBRCT-FLAG (1–1,711 aa), 53BP1 DN/DC
FLAG (1,220–1,711 aa), and 53BP1D1/2N FLAG
(618–1,711 aa). After extensive washing, bound
fractions were resolved in SDS-PAGE and western
blot with FLAG M5 antibody (Sigma).
pT392-MOF Is Critical for Resection
during HR Repair
Because depletion of MOF reduces the
formationof IR-inducedRAD51 foci, a hall-
mark of HR (Sharma et al., 2010), we
examined further the effect of pT392-
MOF mutation on recruitment of HR com-
ponents to DSBs. The frequency of RIF1 colocalization with
53BP1 is significantly higher in postirradiated cells expressing
MOF-T392A than in control cells (Figures7AandS7B).Consistent
with results that p-T392-MOF has a role in HR, a reduced fre-
quency of cells with IR-induced BRCA1, CtIP, RAD51, RPA2,
MRE11, RAP80, and FANCD2 foci was found in mutant MOF-
T392A-expressing cells (Figures 7B–7H), supporting a direct link
between DSB repair by HR and phosphorylation of MOF-T392.
To further determine the role of MOF phosphorylation in DNA
repair protein recruitment, we compared the levels of BRCA1,
RAD51, MRE11 and KU80 at different distances from an I-SceI-
induced DSB site using ChIP analysis with specific primers (Ro-
drigue et al., 2006). Cells enriched in G1 or S/G2 phase
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Figure 7. Phosphorylated MOF-T392 Is Required for HR and HR-Related Protein Recruitment
(A) Colocalization of 53BP1 and RIF1 in cells with and without MOF-T392A.
(B and C) Cells with and without expression of mutant MOF were irradiated with 10 Gy and examined for BRCA1 foci (B) and CtIP foci (C) at the indicated times.
(D) RAD51 foci induced after different doses of ionizing radiation exposure in cells with and without expression of mutant MOF-T392A.
(E–H) Cells with and without expression of mutant MOF-T392A were irradiated with 10 Gy and quantified for foci at different time points postirradiation. (E) RPA2,
(F) MRE11, (G) RAP80, and (H) FANCD2.
(legend continued on next page)
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(Table S1), with and without expression of mutant MOF-T392A,
were induced for I-SceI site cleavage and analyzed by ChIP for
RAD51, MRE11, KU80, MOF, and Flag-tagged MOF-T392A. In
G1 phase cells, the localization and increase in KU80 at close
proximity to the DSB break was unaltered by MOF-T392A
expression, whereas levels of RAD51 at the break site were
significantly reduced in G1 phase cells expressing wild-type or
mutant MOF (Figure 7I). A modest impact of MOF-T392A on the
recruitment of RAD51 was observed in G1/S cells, where the
levels were relatively low as compared to cells expressing wild-
type MOF (Figures 7J and 7K). However, in S/G2 phase cells
the high levels of RAD51 or MRE11 that localized near the break
in cells expressing wild-type MOF were significantly reduced in
cells expressing mutant MOF-T392A (Figures 7L and 7M).
The reduced level of RAD51 at the DSB site inMOF-T392A-ex-
pressing cells could be due to altered recruitment of BRCA1;
therefore, we examined the localization of 53BP1 and BRCA1
in G1 and S/G2 phase cells expressing wild or mutant MOF-
T392A. Although BRCA1 colocalizes with p-T329-MOF foci
postirradiation, no direct interaction was observed between
BRCA1 and MOF by coimmunoprecipitation (Figure S7C). The
levels of RAD51 was similar in cells expressing wild-type or
mutant MOF-T392A (Figure S7D); maximum 53BP1 association
at the DSB site was observed in G1 phase cells expressing either
wild-type or mutant MOF-T392A, whereas minimum levels of
BRCA1were observed (Figure S7E). In contrast, maximum levels
of BRCA1 andminimum levels of the 53BP1 at the DSB site were
observed in S/G2 phase cells expressing wild-type MOF, but
MOF-T392A expression reduced BRCA1 levels and increased
53BP1 levels at the DSB site (Figure S7F).
DISCUSSION
We have identified a mechanism whereby ATM-dependent
phosphorylation of MOF threonine 392 regulates 53BP1-depen-
dent recruitment of proteins involved in the cell-cycle-specific
selection betweenNHEJ andHRDNADSB repair. Cells depleted
for MOF fail to recruit MDC1 and its downstream effectors
53BP1 and BRCA1 to DNA damage foci (Li et al., 2010). Similar
to ATM deficiency, endogenousMOF depletion also results in an
overall defect in DNADSB repair throughout all phases of the cell
cycle (Gupta et al., 2005; Pandita and Hittelman, 1992a, 1992b;
Pandita et al., 1999; Sharma et al., 2010). The loss of ATM-
dependent MOF phosphorylation has no effect on IR-induced
G1 phase cell killing, chromosome damage repair, or MDC1
foci formation. In contrast, MOF-T392 phosphorylation is critical
for cell survival and chromosome damage repair in S and G2
phase. Interestingly, ATM-dependent-MOF phosphorylation in-
creases MOF retention on DNA postirradiation in S/G2 phase
cells. Furthermore, the fact that there is a reduced frequency
of cells with HR-related repairsome foci after MOF-T392A
expression strongly supports the argument that ATM-dependent
phosphorylation of MOF regulates recruitment of HR-related
proteins during the S/G2 phases of the cell cycle.
The 53BP1protein hasbeen implicated in the regulationofDNA
DSBpathway choice (Morales et al., 2003;Ward et al., 2003; Zim-
mermann et al., 2013), and the first effector of 53BP1 was identi-
fied to be RIF1 (Chapman et al., 2013; Di Virgilio et al., 2013;
Escribano-Diaz and Durocher, 2013; Feng et al., 2013; Zimmer-
mann et al., 2013). In BRCA1-deficient cells, suppression of
DNA end resection (Bunting et al., 2010) is critical, and 53BP1
as well as the 53BP1-interacting protein RIF1 have been shown
to be required for inhibition of resection. Accumulation of RIF1
at DSB sites results from its binding to phosphorylated 53BP1
(Anbalagan et al., 2011; Bonetti et al., 2010), and the frequency
of RIF1/53BP1 foci colocalization increases in cells expressing
the MOF-T392A mutant. These results support the notion that
phosphorylated-MOF plays an essential role in regulating recruit-
ment of HR-related proteins to the damaged sites. Furthermore,
we have shown that expression of mutant MOF-T392A results in
failure of 53BP1displacement and reducedBRCA1accumulation
at aDSBsiteduring theS/G2phaseof thecell cycle.Cumulatively,
we have shown that in response toDNAdamage, ATMphosphor-
ylatesMOF,whichpromotesdissociationof a complexcontaining
53BP1 and MOF from the site of damage in S/G2 phase cells in
order toallow forsubsequent recruitmentof the resectionmachin-
ery facilitating HR-dependent repair. As such, this ATM-depen-
dent MOF posttranslational modification mediates DNA DSB
repair pathway choice according to the cell-cycle position.
EXPERIMENTAL PROCEDURES
Cell Survival and Chromosomal Aberration Analysis
Cell survival and chromosomal aberration analyses were carried out as
described previously (Pandita et al., 2006). Cell enrichment in different phases
was achieved by serum deprivation as well as thymidine block (Table S1). For
serum deprivation, cells were incubated until confluence, washed, and incu-
bated for 48 hr in serum-free medium. Cell-cycle analysis by flow cytometry
revealed that more than 95% of cells were in G1 phase of the cell cycle (Pan-
dita and Hittelman, 1992a, 1992b). For S and G2 phase, cells were enriched by
thymidine block and then released. MOF mutants (MOF-T392A and MOF-
T392E) were generated by site-directed mutagenesis, then cloned into
pcDNA3.1 vector, and transfected into 293T, RKO, and U2OS cells. siRNA
treatment of cell lines was performed as described (Gupta et al., 2005, 2008;
Pandita, 2006). Mutant generation, siRNA transfection, immunofluorescence,
and protein retention assay were carried out as previously described (Agarwal
et al., 2008; Gupta et al., 2005, 2008, 2009; Hunt et al., 2007; Kumar et al.,
2011; Pandita et al., 1999, 2006; Pandita, 2006; Sharma et al., 2003a,
2003b, 2010; Singh et al., 2013). Site-directed mutagenesis of MOF-T392 as
well as in vitro kinase assays were performed to confirm that MOF-T392 phos-
phorylation is ATM dependent. A rabbit pT392-MOF polyclonal antibody was
generated. Phosphorylated MOF-T392 foci were determined by immunostain-
ing. The impact of MOF phosphorylation on IR response was determined by
(I–L) Detection of repair proteins at I-SceI-induced DSB sites by ChIP. Cell synchronization, cell-cycle analysis, I-SceI-induced DSB, and ChIP analysis were done
according to the described procedure (Rodrigue et al., 2006). The closest PCR product to the DSB site is 94–378. (I) G1 phase cells expressing wild-type MOF.
(J) G1/S phase cells expressing wild-type MOF.
(K) G1/S phase cells expressing mutant MOF.
(L) S/G2 phase cells expressing wild-type MOF.
(M) S/G2 phase cells expressingmutantMOF-T392A. Error bars represent the SD from three different experiments (*p < 0.05, **p < 0.01, as determined by the chi-
square test).
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clonogenic assay and bymeasuring chromosome aberrations at metaphase in
cells expressing mutant or wild-typeMOF. EndogenousMOFwas depleted by
UTR-specific MOF-siRNA in cells expressing mutant MOF.
Immunofluorescence, Microirradiation, and Protein Retention
Assay
The procedure for immunofluorescence analysis was the same as previously
described (Agarwal et al., 2008; Gupta et al., 2009; Hunt et al., 2007; Pandita
et al., 1999, 2006). For microirradiation, cells transfected with YFP-labeled
ATM or 53BP1 were grown on glass-bottom culture dishes and then microir-
radiated, and the signal was quantified as described (Sharma et al., 2010).
The frequency of colocalization between two proteins was determined by
the procedure described previously (Asaithamby et al., 2011). The procedure
for protein retention assay is same as described (Sharma et al., 2003a, 2003b).
Western Blot Analysis, IP, ChIP, and GST Pull-Down Assay
Western blot analysis, immunoprecipitation (IP) chromatin immunoprecipita-
tion (ChIP), and GST pull-down assay were performed as described in Supple-
mental Experimental Procedures.
Histone Acetyl-Transferase Assay
Plasmid pGEX-4T1 carrying the open reading frame for GST-MOF was muta-
genized to generate T392A and T392E versions. The wild-type and mutant
GST-MOF proteins were expressed in BL21(DE3) cells and were affinity puri-
fied on glutathione Sepharose beads. Equal amounts of the proteins were
incubated with Xenopus core histones, 50 mM Tris (pH 7.5), 100 mM NaCl,
and acetylCoA. Acetylation efficiency was determined by western blotting
with antisera specific for H4K16ac.
In Situ Proximity Ligation Assay
293T cells transiently expressing FLAG-taggedWTorMOF-T392Awere grown
overnight in 16-well chamber slides and were fixed with 4%paraformaldehyde
and permeabilized with 0.2% Tween 20, followed by incubation with a primary
antibody for FLAG for MOF (mouse; Sigma-Aldrich) versus gH2AX (rabbit;
GENTEX) or FLAG versus 53BP1 (rabbit). The PLA assay was performed using
the Duolink PLA kit from OLink Bioscience.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.05.044.
AUTHOR CONTRIBUTIONS
A.G., C.R.H., M.L.H., and T.K.P. designed the research; A.G., C.R.H., M.L.H.,
S.C., D.U., N.H., M.S., D.B.R., W.N.H., A.A., S.N., T.K.H., T.L., and R.K.P. per-
formedexperiments; andA.G.,N.H.,C.R.H., J.K.T., andT.K.P.wrote thepaper.
ACKNOWLEDGMENTS
We thank Maria Jasin, Simmon Boulton, Daniel Durocher, Matthew Porteus,
Tanya Paull, Yali Duo, and Simon Powell for providing reagents. Sincere
thanks are due to Daniel Durocher, Andre Nussenzweig, and to members of
T.K.P.’s laboratory for critical reading and suggestions for the manuscript.
This work has been supported by NIH grants CA129537 and CA154320.
Received: August 14, 2013
Revised: April 24, 2014
Accepted: May 21, 2014
Published: June 19, 2014
REFERENCES
Agarwal, M., Pandita, S., Hunt, C.R., Gupta, A., Yue, X., Khan, S., Pandita,
R.K., Pratt, D., Shay, J.W., Taylor, J.S., and Pandita, T.K. (2008). Inhibition of
telomerase activity enhances hyperthermia-mediated radiosensitization.
Cancer Res. 68, 3370–3378.
Anbalagan, S., Bonetti, D., Lucchini, G., and Longhese, M.P. (2011). Rif1 sup-
ports the function of the CST complex in yeast telomere capping. PLoS Genet.
7, e1002024.
Asaithamby, A., Hu, B., and Chen, D.J. (2011). Unrepaired clustered DNA
lesions induce chromosome breakage in human cells. Proc. Natl. Acad. Sci.
USA 108, 8293–8298.
Bhadra, M.P., Horikoshi, N., Pushpavallipvalli, S.N., Sarkar, A., Bag, I.,
Krishnan, A., Lucchesi, J.C., Kumar, R., Yang, Q., Pandita, R.K., et al.
(2012). The role of MOF in the ionizing radiation response is conserved in
Drosophila melanogaster. Chromosoma 121, 79–90.
Bonetti, D., Clerici, M., Anbalagan, S., Martina, M., Lucchini, G., and Longh-
ese, M.P. (2010). Shelterin-like proteins and Yku inhibit nucleolytic processing
of Saccharomyces cerevisiae telomeres. PLoS Genet. 6, e1000966.
Bothmer, A., Robbiani, D.F., Feldhahn, N., Gazumyan, A., Nussenzweig, A.,
andNussenzweig,M.C. (2010). 53BP1 regulatesDNA resection and the choice
between classical and alternative end joining during class switch recombina-
tion. J. Exp. Med. 207, 855–865.
Bothmer, A., Robbiani, D.F., Di Virgilio, M., Bunting, S.F., Klein, I.A., Feldhahn,
N., Barlow, J., Chen, H.T., Bosque, D., Callen, E., et al. (2011). Regulation of
DNA end joining, resection, and immunoglobulin class switch recombination
by 53BP1. Mol. Cell 42, 319–329.
Bouwman, P., Aly, A., Escandell, J.M., Pieterse, M., Bartkova, J., van der Gul-
den, H., Hiddingh, S., Thanasoula, M., Kulkarni, A., Yang, Q., et al. (2010).
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative
and BRCA-mutated breast cancers. Nat. Struct. Mol. Biol. 17, 688–695.
Bunting, S.F., Calle´n, E., Wong, N., Chen, H.T., Polato, F., Gunn, A., Bothmer,
A., Feldhahn, N., Fernandez-Capetillo, O., Cao, L., et al. (2010). 53BP1 inhibits
homologous recombination in Brca1-deficient cells by blocking resection of
DNA breaks. Cell 141, 243–254.
Callen, E., Di Virgilio, M., Kruhlak, M.J., Nieto-Soler, M., Wong, N., Chen, H.T.,
Faryabi, R.B., Polato, F., Santos, M., Starnes, L.M., et al. (2013). 53BP1 medi-
ates productive and mutagenic DNA repair through distinct phosphoprotein
interactions. Cell 153, 1266–1280.
Chapman, J.R., Taylor, M.R., and Boulton, S.J. (2012). Playing the end game:
DNA double-strand break repair pathway choice. Mol. Cell 47, 497–510.
Chapman, J.R., Barral, P., Vannier, J.B., Borel, V., Steger, M., Tomas-Loba, A.,
Sartori, A.A., Adams, I.R., Batista, F.D., and Boulton, S.J. (2013). RIF1 is
essential for 53BP1-dependent nonhomologous end joining and suppression
of DNA double-strand break resection. Mol. Cell 49, 858–871.
Di Virgilio, M., Callen, E., Yamane, A., Zhang, W., Jankovic, M., Gitlin, A.D.,
Feldhahn, N., Resch, W., Oliveira, T.Y., Chait, B.T., et al. (2013). Rif1 prevents
resection of DNA breaks and promotes immunoglobulin class switching.
Science 339, 711–715.
Escribano-Diaz, C., and Durocher, D. (2013). DNA repair pathway choice—a
PTIP of the hat to 53BP1. EMBO Rep. 14, 665–666.
Feng, L., Fong, K.W., Wang, J., Wang, W., and Chen, J. (2013). RIF1 counter-
acts BRCA1-mediated end resection during DNA repair. J. Biol. Chem. 288,
11135–11143.
Fredriksson, S., Gullberg, M., Jarvius, J., Olsson, C., Pietras, K., Gu´stafsdo´ttir,
S.M., Ostman, A., and Landegren, U. (2002). Protein detection using proximity-
dependent DNA ligation assays. Nat. Biotechnol. 20, 473–477.
Fu¨llgrabe, J., Lynch-Day, M.A., Heldring, N., Li, W., Struijk, R.B., Ma, Q.,
Hermanson, O., Rosenfeld, M.G., Klionsky, D.J., and Joseph, B. (2013). The
histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of
autophagy. Nature 500, 468–471.
Gupta, A., Sharma, G.G., Young, C.S., Agarwal, M., Smith, E.R., Paull, T.T.,
Lucchesi, J.C., Khanna, K.K., Ludwig, T., and Pandita, T.K. (2005). Involve-
ment of human MOF in ATM function. Mol. Cell. Biol. 25, 5292–5305.
Gupta, A., Guerin-Peyrou, T.G., Sharma, G.G., Park, C., Agarwal, M., Ganju,
R.K., Pandita, S., Choi, K., Sukumar, S., Pandita, R.K., et al. (2008). The
188 Cell Reports 8, 177–189, July 10, 2014 ª2014 The Authors
mammalian ortholog of Drosophila MOF that acetylates histone H4 lysine 16 is
essential for embryogenesis and oncogenesis. Mol. Cell. Biol. 28, 397–409.
Gupta, A., Yang, Q., Pandita, R.K., Hunt, C.R., Xiang, T., Misri, S., Zeng, S.,
Pagan, J., Jeffery, J., Puc, J., et al. (2009). Cell cycle checkpoint defects
contribute to genomic instability in PTEN deficient cells independent of DNA
DSB repair. Cell Cycle 8, 2198–2210.
Gupta, A., Hunt, C.R., Chakraborty, S., Pandita, R.K., Yordy, J., Ramnarain,
D.B., Horikoshi, N., and Pandita, T.K. (2014). Role of 53BP1 in the regulation
of DNA double-strand break repair pathway choice. Radiat. Res. 181, 1–8.
Hegde, M.L., Banerjee, S., Hegde, P.M., Bellot, L.J., Hazra, T.K., Boldogh, I.,
and Mitra, S. (2012). Enhancement of NEIL1 protein-initiated oxidized DNA
base excision repair by heterogeneous nuclear ribonucleoprotein U (hnRNP-U)
via direct interaction. J. Biol. Chem. 287, 34202–34211.
Hunt, C.R., Pandita, R.K., Laszlo, A., Higashikubo, R., Agarwal, M., Kitamura, T.,
Gupta, A., Rief, N., Horikoshi, N., Baskaran, R., et al. (2007). Hyperthermia acti-
vates a subset of ataxia-telangiectasia mutated effectors independent of DNA
strand breaks and heat shock protein 70 status. Cancer Res. 67, 3010–3017.
Kakarougkas, A., Ismail, A., Klement, K., Goodarzi, A.A., Conrad, S., Freire, R.,
Shibata, A., Lobrich, M., and Jeggo, P.A. (2013). Opposing roles for 53BP1
during homologous recombination. Nucleic Acids Res. 41, 9719–9731.
Kumar, R., Hunt, C.R., Gupta, A., Nannepaga, S., Pandita, R.K., Shay, J.W.,
Bachoo, R., Ludwig, T., Burns, D.K., and Pandita, T.K. (2011). Purkinje cell-
specific males absent on the first (mMof) gene deletion results in an ataxia-
telangiectasia-like neurological phenotype and backward walking in mice.
Proc. Natl. Acad. Sci. USA 108, 3636–3641.
Lee, J.H., and Paull, T.T. (2004). Direct activation of the ATM protein kinase by
the Mre11/Rad50/Nbs1 complex. Science 304, 93–96.
Li, X., Corsa, C.A., Pan, P.W., Wu, L., Ferguson, D., Yu, X., Min, J., and Dou, Y.
(2010). MOF and H4 K16 acetylation play important roles in DNA damage
repair by modulating recruitment of DNA damage repair protein Mdc1. Mol.
Cell. Biol. 30, 5335–5347.
Matsuoka, S., Ballif, B.A., Smogorzewska, A., McDonald, E.R., 3rd, Hurov,
K.E., Luo, J., Bakalarski, C.E., Zhao, Z., Solimini, N., Lerenthal, Y., et al.
(2007). ATM and ATR substrate analysis reveals extensive protein networks
responsive to DNA damage. Science 316, 1160–1166.
Minter-Dykhouse, K., Ward, I., Huen, M.S., Chen, J., and Lou, Z. (2008).
Distinct versus overlapping functions of MDC1 and 53BP1 in DNA damage
response and tumorigenesis. J. Cell Biol. 181, 727–735.
Morales, J.C., Xia, Z., Lu, T., Aldrich, M.B., Wang, B., Rosales, C., Kellems,
R.E., Hittelman, W.N., Elledge, S.J., and Carpenter, P.B. (2003). Role for the
BRCA1 C-terminal repeats (BRCT) protein 53BP1 in maintaining genomic
stability. J. Biol. Chem. 278, 14971–14977.
Nakamura, K., Sakai, W., Kawamoto, T., Bree, R.T., Lowndes, N.F., Takeda,
S., and Taniguchi, Y. (2006). Genetic dissection of vertebrate 53BP1: a major
role in non-homologous end joining of DNA double strand breaks. DNA Repair
(Amst.) 5, 741–749.
Obradovic, Z., Peng, K., Vucetic, S., Radivojac, P., and Dunker, A.K. (2005).
Exploiting heterogeneous sequence properties improves prediction of protein
disorder. Proteins 61 (Suppl 7), 176–182.
Oksenych, V., Alt, F.W., Kumar, V., Schwer, B., Wesemann, D.R., Hansen, E.,
Patel, H., Su, A., and Guo, C. (2012). Functional redundancy between repair
factor XLF and damage response mediator 53BP1 in V(D)J recombination
and DNA repair. Proc. Natl. Acad. Sci. USA 109, 2455–2460.
Pandita, T.K. (2003). A multifaceted role for ATM in genome maintenance.
Expert Rev. Mol. Med. 5, 1–21.
Pandita, T.K. (2006). Role of mammalian Rad9 in genomic stability and ionizing
radiation response. Cell Cycle 5, 1289–1291.
Pandita, T.K., and Hittelman, W.N. (1992a). The contribution of DNA and
chromosome repair deficiencies to the radiosensitivity of ataxia-telangiecta-
sia. Radiat. Res. 131, 214–223.
Pandita, T.K., and Hittelman, W.N. (1992b). Initial chromosome damage but
not DNA damage is greater in ataxia telangiectasia cells. Radiat. Res. 130,
94–103.
Pandita, T.K., Westphal, C.H., Anger, M., Sawant, S.G., Geard, C.R., Pandita,
R.K., and Scherthan, H. (1999). Atm inactivation results in aberrant telomere
clustering during meiotic prophase. Mol. Cell. Biol. 19, 5096–5105.
Pandita, T.K., Lieberman, H.B., Lim, D.S., Dhar, S., Zheng, W., Taya, Y., and
Kastan, M.B. (2000). Ionizing radiation activates the ATM kinase throughout
the cell cycle. Oncogene 19, 1386–1391.
Pandita, R.K., Sharma, G.G., Laszlo, A., Hopkins, K.M., Davey, S., Chakhparo-
nian, M., Gupta, A., Wellinger, R.J., Zhang, J., Powell, S.N., et al. (2006).
Mammalian Rad9 plays a role in telomere stability, S- and G2-phase-specific
cell survival, and homologous recombinational repair. Mol. Cell. Biol. 26,
1850–1864.
Peterson, C.L., and Almouzni, G. (2013). Nucleosome dynamics as modular
systems that integrate DNA damage and repair. Cold Spring Harb. Perspect.
Biol. 5, 5.
Pierce, A.J., Johnson, R.D., Thompson, L.H., and Jasin, M. (1999). XRCC3
promotes homology-directed repair of DNA damage in mammalian cells.
Genes Dev. 13, 2633–2638.
Rodrigue, A., Lafrance, M., Gauthier, M.C., McDonald, D., Hendzel, M., West,
S.C., Jasin, M., and Masson, J.Y. (2006). Interplay between human DNA repair
proteins at a unique double-strand break in vivo. EMBO J. 25, 222–231.
Sartori, A.A., Lukas, C., Coates, J., Mistrik, M., Fu, S., Bartek, J., Baer, R.,
Lukas, J., and Jackson, S.P. (2007). HumanCtIP promotes DNA end resection.
Nature 450, 509–514.
Sharma, G.G., Gupta, A., Wang, H., Scherthan, H., Dhar, S., Gandhi, V., Iliakis,
G., Shay, J.W., Young, C.S., and Pandita, T.K. (2003a). hTERT associates with
human telomeres and enhances genomic stability and DNA repair. Oncogene
22, 131–146.
Sharma, G.G., Hwang, K.K., Pandita, R.K., Gupta, A., Dhar, S., Parenteau, J.,
Agarwal, M., Worman, H.J., Wellinger, R.J., and Pandita, T.K. (2003b). Human
heterochromatin protein 1 isoforms HP1(Hsalpha) and HP1(Hsbeta) interfere
with hTERT-telomere interactions and correlate with changes in cell growth
and response to ionizing radiation. Mol. Cell. Biol. 23, 8363–8376.
Sharma, G.G., So, S., Gupta, A., Kumar, R., Cayrou, C., Avvakumov, N.,
Bhadra, U., Pandita, R.K., Porteus, M.H., Chen, D.J., et al. (2010). MOF and
histone H4 acetylation at lysine 16 are critical for DNA damage response
and double-strand break repair. Mol. Cell. Biol. 30, 3582–3595.
Shiloh, Y., and Ziv, Y. (2013). The ATM protein kinase: regulating the cellular
response to genotoxic stress, and more. Nat. Rev. Mol. Cell Biol. 14, 197–210.
Singh, M., Hunt, C.R., Pandita, R.K., Kumar, R., Yang, C.R., Horikoshi, N.,
Bachoo, R., Serag, S., Story, M.D., Shay, J.W., et al. (2013). Lamin A/C deple-
tion enhances DNA damage-induced stalled replication fork arrest. Mol. Cell.
Biol. 33, 1210–1222.
So¨derberg, M., and Lang, M.A. (2006). Megaprimer-based methodology for
deletion of a large fragment within a repetitive polypyrimidine-rich DNA. Mol.
Biotechnol. 32, 65–71.
Symington, L.S., and Gautier, J. (2011). Double-strand break end resection
and repair pathway choice. Annu. Rev. Genet. 45, 247–271.
Taipale, M., Rea, S., Richter, K., Vilar, A., Lichter, P., Imhof, A., and Akhtar, A.
(2005). hMOF histone acetyltransferase is required for histone H4 lysine 16
acetylation in mammalian cells. Mol. Cell. Biol. 25, 6798–6810.
Tang, J., Cho, N.W., Cui, G., Manion, E.M., Shanbhag, N.M., Botuyan, M.V.,
Mer, G., and Greenberg, R.A. (2013). Acetylation limits 53BP1 association
with damaged chromatin to promote homologous recombination. Nat. Struct.
Mol. Biol. 20, 317–325.
Ward, I.M., Minn, K., van Deursen, J., and Chen, J. (2003). p53 Binding protein
53BP1 is required for DNA damage responses and tumor suppression in mice.
Mol. Cell. Biol. 23, 2556–2563.
West, S.C. (2003). Molecular views of recombination proteins and their control.
Nat. Rev. Mol. Cell Biol. 4, 435–445.
Zimmermann,M., Lottersberger, F., Buonomo, S.B., Sfeir, A., and de Lange, T.
(2013). 53BP1 regulates DSB repair using Rif1 to control 50 end resection.
Science 339, 700–704.
Cell Reports 8, 177–189, July 10, 2014 ª2014 The Authors 189
